Chemo Pharma Laboratories Ltd
Know More29.77↑1.41 (4.97%)
12:00 AM,29th Sep 2023BSE : 506365
NSE :
Sector : Health care
ISIN Code : INE320M01019
- NSE
- BSE
- 1D
- 5D
- 1M
- 6M
- 1Y
- 2Y
- 5Y
- MAX
Last Updated: Sep 29 2023 | 12:00 AM IST
| Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Chemo Pharma Laboratories Ltd
Chemo Pharma Laboratories Limited has been an established Company since 1942 and has been making Pharmaceuticals and also had diversified into bulk drugs. However due to increase in competition and flow of new drugs the Company had to dispose the business and pay all its liabilities and dues. Presently the Company has its own cash resource with this the Company is proposing to diversify and to take over Sick Company which has excellent future potential. The Company is in advance in the negotiation to some other company and soon rehab to acquire business in Power and Chemicals.
News
View MoreAnnouncement
View MoreChemo Pharma Laboratories Ltd - Key Fundamentals
| PARAMETER | VALUES |
|---|---|
| Market Cap (₹ Cr) | 4 |
| EPS - TTM (₹) [S] | 6.16 |
| P/E Ratio (X) [S] | 0.38 |
| Face Value (₹) | 10 |
| Latest Dividend (%) | - |
| Latest Dividend Date | - |
| Dividend Yield (%) | - |
| Book Value Share (₹) [S] | 77.35 |
| P/B Ratio (₹) [S] | 0.38 |
| [*C] Consolidated [*S] Standalone | |
Funds Owing this Stock
| Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
|---|
Research Reports
| Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
|---|---|---|---|---|
| Data Not Found |
Stock Strength
| Today's Low/High | 29.77 29.77 |
| Week Low/High | 28.31 32.00 |
| Month Low/High | 28.31 37.00 |
| Year Low/High | 27.17 48.00 |
| All time Low/High | 1.60 195.00 |
Share Price Returns
| Period | BSE | NSE | SENSEX | NIFTY |
|---|---|---|---|---|
| 1 Week | -3.97% | % | -0.27 | -0.18% |
| 1 Month | -17.31% | % | 1.16 | 1.53% |
| 3 Month | -12.83% | % | 2.99 | 3.51% |
| 6 Month | % | % | 14.26 | 15.85% |
| 1 Year | -14.94% | % | 16.70 | 16.77% |
| 3 Year | 53.22% | % | 73.35 | 74.99% |
Financials
- Financial Overview
- Income Statement
- Balance Sheet
- Profit & Loss
- Cash Flow Statement
- Ratios
- Revenue (Rs Cr)
- Net Profit (Rs Cr)
- Operating Profit (Rs Cr)
- Earnings Per Share(Rs)
- Book Value(Rs per share)
- Net Worth(Rs Cr)
- Divident(%)
- Dividend Payout(Rs Cr)
Bulk/ Block
| Date | Client Name | Exchange | Transaction | Quantity | Price |
|---|---|---|---|---|---|
| 20-09-2022 | NITIN VISHWANATH DHARESHWAR | BSE | SELL | 8326 | 49.08 |
| 13-09-2022 | DIVYA KANDA | BSE | SELL | 10000 | 38.02 |
| 03-01-2022 | HARSH AGARWAL | BSE | SELL | 8104 | 34.40 |
Peer Group Comparison
- Ratio Performance
- Stock Performance
| Name | Price(In Rs) | Chg(%) | Mkt Cap(Rs Cr) | Sales(Rs Cr) | Profit(Rs Cr) | EPS(Rs) | P/E(x) |
|---|
Shareholding Pattern
- Total shareholdings
| Category | Share(%) |
|---|---|
| Promoter | 27.89 |
| Financial Institutions Banks | 0.17 |
| Foreign Institutional Investors | 0.00 |
| Insurance Companies | 0.00 |
| Mutual Funds Uti | 0.00 |
| Other Institutional Investors | 0.20 |
| Indian Public | 65.56 |
| Others Non Institutional Investors | 6.19 |
| Custodians | 0.00 |
Corporate Action
| Announcement Date | Purpose | From | To | Remarks |
|---|---|---|---|---|
| Data Not Found |
Price History
Search for Price History
| Date | Open | High | Low | Close | Shares | Trades |
|---|---|---|---|---|---|---|
| Data Not Found |
Load more
Company Info
Company Information
Executive Director & CFO : Ashok Somani
Independent Director : Toby Antony
Director : Shanta Somani
Independent Director : Mathura Prasad Sharma
Director & Chief Executive Off : Bhavin Sheth
Independent Director : Nandkumar Pareek
Registered Office: 5 Kumud Apartment CHS Ltd, Karnik Road Chikan Ghar Kalyan,Thane,Maharashtra-421301 Ph: 91-022-22078381/22078382
Email:chemopharmalab@gmail.com
